Neutropenia and Neutropenic Complications in ABVD Chemotherapy for Hodgkin Lymphoma

Advances in Hematology - Egypt
doi 10.1155/2011/656013
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Hindawi Limited

Related search

9225 Hodgkin Lymphoma Treatment With ABVD in the US and the EU: Neutropenia Occurrence and Impaired Chemotherapy Delivery

European Journal of Cancer, Supplement
Cancer ResearchOncology
2009English

Maternal ABVD Chemotherapy for Hodgkin Lymphoma in a Dichorionic Diamniotic Pregnancy: A Case Report

BMC Pregnancy and Childbirth
GynecologyObstetrics
2020English

Rituximab Plus ABVD in Newly Diagnosed Nodular Lymphocyte-Predominant Hodgkin Lymphoma

British Journal of Haematology
Hematology
2016English

Excellent Outcome in Hodgkin Lymphoma With ABVD and CMT: A Single-Centre Retrospective Analysis

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Occurrence of Sarcoidosis After Chemotherapy for Non-Hodgkin Lymphoma

Korean Journal of Internal Medicine
Internal Medicine
2016English

Eruptive Pseudoangiomatosis in a Child Undergoing Chemotherapy for Hodgkin Lymphoma

Pediatric Blood and Cancer
OncologyChild HealthHematologyPerinatologyMedicinePediatrics
2011English

EBV-Positive Plasmablastic Lymphoma Mimicking Reactive Lymphadenopathy Versus Recurrent Hodgkin Lymphoma Following Chemotherapy for Stage II Classical Hodgkin Lymphoma

Journal of Tumour Research & Reports
2018English

Non-Hodgkin Lymphoma Secondary to Cancer Chemotherapy

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2007English

Chemotherapy or Combined Modality Therapy for Early-Stage Hodgkin Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy